STAT3 and COVID-19: The ability of IL-33 to activate both the IL-33/p38/GATA3 and IL-33/MAPK/STAT3 pathways suggests that IL-33 plays a key role in the regulation of ILC2 in pulmonary inflammation, which provides a new perspective for research into the mechanism of the secondary pulmonary symptoms of COVID-19.